CLINICAL_TRIALS
trial_result
· 2012-01-19
Clinical Trial Update: Safety and Efficacy of AGN201781 in Neuropathic Pain [Phase 2]
Summary
Allergan's AGN201781 in neuralgia (neuropathic pain) underwent a Phase 2 trial that was terminated. Results from the study were posted on 2012-01-19.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Neuralgia | Phase 2 | Status: TERMINATED | Results posted: 2012-01-19